Palivizumab | 188039-54-5 - MedChemExpress
2023-02-24 15:34 作者:bili_92778524386 | 我要投稿
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Palivizumab
品牌:MedChemExpress (MCE)
Drug_Names:Palivizumab
CAS:188039-54-5
产品活性:Palivizumab (MEDI 493) 是一种人源化呼吸道合胞病毒单克隆抗体,可减少呼吸道合胞病毒感染 (RSV)[1]。
存储条件:Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献:
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.